Identification by photoaffinity labelling of a pyridine nucleotide-dependent tri-iodothyronine-binding protein in the cytosol of cultured astroglial cells.
High-affinity 3,3',5-tri-iodo-L-thyronine (T3) binding (Kd approximately 0.3 nM) to the cytosol of cultured rat astroglial cells was strongly activated in the presence of pyridine nucleotides. A 35 kDa pyridine nucleotide-dependent T3-binding polypeptide (35K-TBP) was photoaffinity labelled using underivatized [125I]T3 in the presence of pyridine nucleotides and the free-radical scavenger dithiothreitol. Maximum activations of T3 binding and 35K-TBP photolabelling were obtained at approx. 1 x 10(-7) M NADP+ or NADPH, or 1 x 10(-4) M NADH. NAD+ and other nucleotides were without effect. NADPH is the form which activates T3 binding and 35K-TBP photolabelling, since cytosol contains NADP(+)-reducing activity, and the activation of both processes in the presence of NADPH and NADP+ was prevented by an exogenous NADPH oxidation system. NADPH behaved as an allosteric activator of T3 binding. The NADPH oxidation system promoted the release of bound T3 in the absence of any change in the total concentration of the hormone. The 35K-TBP photolabelling and [125I]T3 binding were similarly inhibited by non-radioactive T3 (half-maximum effect at 0.5-1.0 nM T3). The concentrations of iodothyronine analogues that inhibited both processes were correlated (3,3',5-tri-iodo-D-thyronine > or = T3 > L-thyroxine > tri-iodothyroacetic acid > 3,3'5'-tri-iodo-L-thyronine). Molecular sieving and density-gradient centrifugation of cytosol identified a 65 kDa T3-binding entity, which included the 35K-TBP. These results indicate that 35K-TBP is the cytosolic entity involved in the pyridine nucleotide-dependent T3 binding, and suggest that the sequestration and release of intracellular thyroid hormones are regulated by the redox state of astroglial cell compartment(s).
Beslin
A
A
Unité de Recherches sur la Glande Thyroïde et la Régulation Hormonale (U. 96), Institut National de la Santé et de la Recherche Médicale, Le Kremlin-Bicêtre, France.
Vié
M P
MP
Blondeau
J P
JP
Francon
J
J
D000345:Affinity Labels; D000494:Allosteric Regulation; D000818:Animals; D001253:Astrocytes / Q000737:chemistry*; D002352:Carrier Proteins / Q000032:analysis* / Q000378:metabolism; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D003600:Cytosol / Q000737:chemistry*; D004229:Dithiothreitol / Q000494:pharmacology; D007457:Iodine Radioisotopes; D008565:Membrane Proteins / Q000032:analysis* / Q000378:metabolism; D009243:NAD / Q000494:pharmacology; D009249:NADP / Q000494:pharmacology*; D010084:Oxidation-Reduction; D010777:Photochemistry; D051381:Rats; D017207:Rats, Sprague-Dawley; D013963:Thyroid Hormones; D014284:Triiodothyronine / Q000378:metabolism; D000097810:Thyroid Hormone-Binding Proteins
D000345:Affinity Labels; D002352:Carrier Proteins; D004229:Dithiothreitol; D007457:Iodine Radioisotopes; D008565:Membrane Proteins; D009243:NAD; D009249:NADP; D013963:Thyroid Hormones; D014284:Triiodothyronine; D000097810:Thyroid Hormone-Binding Proteins